Series A funding round for Kinnate Biopharma raising $22M in March 2018
Series A funding round for Kinnate Biopharma raising $22M in March 2018
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$195M
Top Valuation
-
Kinnate Biopharma raised $22M in a Series A round.
The round was announced on 03/01/18.